HONG KONG, June 19, 2026 /PRNewswire/ -- DFSK, the new energy vehicle brand under SERES Group (HKEX: 09927), today unveiled the right-hand-drive (RHD) version of the E5 PLUS at the 2026 International Automotive & Supply Chain Expo (Hong Kong), marking a major milestone in the brand's global expansion.

The debut of the E5 PLUS RHD not only broadens DFSK's product portfolio, but also reflects the brand's continued evolution into a global provider of intelligent, green mobility solutions designed around the needs of local markets.

Accelerating DFSK's Global Journey

Following the success of the E5 PLUS in North Africa and South America, the launch of the RHD variant represents another significant step in DFSK's international growth. As DFSK expands its presence across global markets, the company continues to strengthen the development of its regional centers and ecosystems. Highly automated production facilities in Indonesia and Vietnam enable DFSK to respond more efficiently to local demand.

Amy Gong, President of DFSK, said: "The E5 PLUS marks the beginning of a comprehensive renewal of our product portfolio. We will continue to strengthen our capabilities in technology and intelligent innovation, enrich our product offerings, accelerate our global expansion, deepen our local operations, and deliver increasingly competitive products and services that provide customers around the world with greener, smarter mobility experiences."

Engineered for Right-Hand-Drive Markets

The E5 PLUS is a strategic global new energy model developed to meet the needs of modern family mobility. Powered by the SERES Super Hybrid System, the E5 PLUS intelligently adapts its driving modes to different road conditions through advanced energy management, delivering both efficiency and confidence on longer journeys with a combined driving range of up to 1,200km WLTP.

The intelligent driving variant of the E5 PLUS RHD features driver assistance solution equipped with 5mm-wave radars and 22 sensing units, complemented by functions including a 540-degree panoramic view, enhancing convenience and safety across daily commuting and more challenging driving environments.

Recognizing the unique characteristics of RHD markets, particularly across Southeast Asia, the E5 PLUS RHD has been specifically optimized for regional driving conditions, weather patterns and user preferences. Driver assistance functions such as Lane Centering Control (LCC) and Adaptive Cruise Control (ACC) have been refined for local driving scenarios, while voice interaction and user interface logic have been adapted to regional usage habits.

The infotainment system now supports Traditional Chinese (Hong Kong), Thai, Indonesian, Malay and Vietnamese, alongside an upgraded connected ecosystem offering seamless compatibility with systems and applications like CarPlay and Spotify, creating a more intuitive and enjoyable ownership experience.

The E5 PLUS RHD will be progressively introduced across markets including Indonesia and Hong Kong SAR, offering customers an attractive combination of intelligent technology, practicality and value.

New Identity, New Product and New Service

Guided by its values of accessible technology, green innovation, accountability and continuous progress, DFSK is committed to advancing vehicle technology while building a stronger ecosystem that creates value for customers, partners and communities. By making intelligent mobility more attainable, DFSK strives to drive progress through smarter, more comfortable and more efficient transportation solutions that evolve with the changing needs of modern families.

To support this vision, DFSK is actively strengthening its global partner ecosystem through long-term collaboration and comprehensive support.

At the same time, DFSK has introduced a new global service framework built on agile quality management, professional talent development, an efficient spare parts network and a digital service platform. Spanning five critical dimensions—network capability, operational systems, people, technical expertise and parts availability—the new architecture is designed to provide peace of mind and a service experience that exceeds expectations.

With a renewed brand identity, an expanding portfolio of new energy products and a stronger service commitment, DFSK is poised to further strengthen its position in international markets and play an increasingly important role in shaping the future of global sustainable mobility.

About DFSK

Founded in 2003, DFSK is dedicated to providing passenger vehicles, commercial vehicles, and advanced mobility services to consumers around the world. To date, more than 5 million DFSK vehicles have been delivered across over 70 countries and regions. Driven by continuous innovation, DFSK is rapidly evolving into a new energy and intelligent automotive brand.

For more information, please check our website www.dfsk.com

Facebook | Instagram | YouTube

香港2026年6月18日 /美通社/ -- 賽力斯（股份代號：09927.HK）旗下新能源汽車品牌DFSK，於2026國際汽車及供應鏈博覽會上，正式推出E5 PLUS右軚版車型，以拓展國際市場，讓更多海外用戶體驗綠色智慧出行。E5 PLUS右軚版的推出，亦是DFSK品牌進一步完善全球業務部署、逐步轉型為綠色智能汽車品牌的重要一步。

深化本地化部署，助力品牌拓展海外市場

此前，E5 PLUS在北非、南美等市場廣受好評，銷量成績斐然。今次推出E5 PLUS右軚版，不僅豐富了其國際化產品線，更是DFSK品牌落實全球戰略佈局的成果體現。DFSK同時積極在全球範圍內建立本地化中心及培育本地生態圈，並於印尼、越南等地投資興建高度自動化的汽車製造廠，從而更有效地服務海外用戶。

DFSK總裁龔海燕表示，以E5 PLUS為起點，DFSK將全面更新旗下的產品線，持續強化科技與智能創新，不斷豐富產品選擇。同時，品牌將加速拓展全球市場並深耕本地化營運，透過更具競爭力的產品和服務，為全球用戶帶來綠色、智能的出行體驗。

右軚專屬配置，滿足多元化海外需求

E5 PLUS是DFSK面向全球市場推出的新能源戰略車型，專為滿足現代家庭的出行需求而設。車輛搭載SERES超級混能系統，內置智能系統可根據不同路況切換對應的駕駛模式，並透過智能能量管理系統實現更出眾的油耗表現，綜合續航里程長達1200公里。此外，右軚智駕版採用了全新的輔助駕駛系統，配備5顆毫米波雷達及22個感應器，輔以540°全景影像等功能，為用戶日常通勤及應付複雜路況提供更便捷和安全的保障。

同時，結合東南亞地區天氣多變、路況複雜以及當地用戶的汽車使用習慣，E5 PLUS右軚智駕版特別針對LCC、ACC等輔助駕駛系統進行改良，並調整了語音互動及介面邏輯等軟硬件設定，新增泰語、印尼語、馬來西亞語、越南語及香港繁體中文5種系統語言。汽車內置的智能系統亦同步升級，全面支援CarPlay和Spotify等應用程式，完美契合不同用戶的使用習慣，提供更流暢舒適的用車體驗。

E5 PLUS右軚版將在印尼、香港等市場陸續上市。憑藉其出眾的品質表現及高性價比優勢，勢必成為更多用戶綠色出行的理想之選。

新形象、新產品、新服務，共創更美好的未來

在「普及智能科技、綠色創新、可靠服務、持續向前」的品牌價值觀指引下，DFSK不僅致力於產品技術的創新，還持續建立更完善的服務與業務網絡。DFSK旨在滿足全球家庭不斷變化的用車需求，為消費者提供更經濟、更智能、更舒適的出行體驗，同時推動合作夥伴健康成長，共同創造更美好的生活與未來，實踐「Drives for better/馭見更好」的願景。

為此，DFSK正積極構建合作夥伴體系，提供全方位支援，攜手實現長期共贏發展。

與此同時，DFSK推出了全新的服務架構，以靈活高效的品質管理、專業人才培訓、高效零件網絡及數碼化服務中樞為支撐。新架構從銷售網絡、營運體系、團隊人員、技術專長及零件供應五大範疇切入，保障服務的全面性與前瞻性，為全球用戶帶來「安心、信賴、超越期待」的售後服務體驗。

透過新形象、新產品、新服務，未來DFSK將進一步鞏固在全球市場的優勢，成為全球新能源汽車領域的中堅力量。

欲知更多詳情，歡迎瀏覽官方網站：www.dfsk.com

關於DFSK

DFSK成立於2003年，是賽力斯集團（股份代號：09927.HK）旗下子品牌，致力為全球消費者提供領先的汽車產品與服務。DFSK全球汽車累計銷量已突破500萬輛，業務覆蓋70餘個國家和地區。秉持持續創新，DFSK正全速推進，轉型成為智能新能源汽車品牌。

Shares of Intel Corporation (INTC.US) proliferated 8.9% in pre-market trading to USD131.82.

US President Donald Trump posted on the Truth Social platform that Intel reached an agreement with Apple Inc. (AAPL.US) to design and manufacture chips in the US.

With backing from the US government, Intel's share price has cumulatively shot up by more than 4.6x over the past 12 months, with its market cap hiking to USD608.7 billion.
~

AASTOCKS Financial News
Website: www.aastocks.com

GUANGZHOU, China, June 18, 2026 /PRNewswire/ -- MINISO Group Holding Limited (NYSE: MNSO; HKEX: 9896) ("MINISO", "MINISO Group" or the "Company"), a global high-growth value retailer offering a variety of trendy lifestyle products featuring distinctive IP designs, today announced that all the proposed resolutions submitted for shareholders' approval set out in the notice of its annual general meeting were duly adopted at the meeting held in Hong Kong today.

About MINISO Group

MINISO Group is a global high-growth value retailer offering a variety of trendy lifestyle products featuring distinctive IP designs. Since opening our first store in Chinese mainland in 2013, the Company has successfully built two brands – "MINISO" and "TOP TOY". The Company's flagship brand "MINISO" has grown into a globally recognized retail brand that offers a frequently-refreshed assortment of lifestyle products through an extensive store network worldwide. The Company's products cover diverse consumer needs and consumers are drawn to MINISO for our products' trendiness, creativeness, high quality and affordability. For more information, please visit https://ir.miniso.com/.

Investor Relations Contact:

MINISO Group Holding Limited
Email: [email protected]
Phone: +86 (20) 36228788 Ext.8039

US President Donald Trump said Apple Inc. (AAPL.US) agreed to partner with Intel Corporation (INTC.US) to design and manufacture chips in the US.

At the moment, Apple relies heavily on Taiwan Semiconductor Manufacturing Company Ltd. (TSM.US), whose advanced production lines must also meet demand from NVIDIA Corporation (NVDA.US) and Advanced Micro Devices, Inc. (AMD.US).

The US government acquired a 10% stake in Intel last year and announced plans to invest approximately USD10 billion in the company to build or expand factories in the US.

The White House has been strengthening safeguards for critical minerals and semiconductor supply chains to reduce reliance on China.
~

AASTOCKS Financial News
Website: www.aastocks.com

SK Hynix shares set a record high, reaching a peak of KRW2.701 million, and were last up 6.98% at KRW2.697 million. In Hong Kong, XL2CSOPHYNIX (07709.HK) elevated 16.92% to HKD169.3, with a turnover of 54.7682 million shares, involving HKD8.73 billion.

The company said it delivered samples of its HBM4E, designed for next-generation AI processors, to major customers. It will work closely with partners to proceed with mass production in a timely manner.

HBM4E is the seventh-generation HBM, a high-performance DRAM designed for rapid data processing. It is used in GPU and other AI accelerators requiring strong computing power.

Meanwhile, the previous-generation HBM4 will be used in NVIDIA Corporation (NVDA.US)'s Vera Rubin AI supercomputer, which is forecast to be launched in 3Q26. HBM4E is estimated to be applied to the Vera Rubin Ultra platform next year.
~

AASTOCKS Financial News
Website: www.aastocks.com

SUZHOU, China, June 18, 2026 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), announced that its Biosafety Testing Center in Suzhou has successfully passed a Good Manufacturing Practice (GMP) inspection by the European Medicines Agency (EMA) with zero critical findings. This marks the fourth time the facility has successfully received EMA GMP certificate. 

The inspection supported the European Union marketing authorization application for a total of 19 biologics from 13 clients, with the majority developed and manufactured on WuXi Biologics' integrated platform. These products span a range of biologics modalities, including antibodies, enzymes, and fusion proteins. The EMA inspection focused on biosafety quality control testing for cell banks and commercial unprocessed bulk associated with these products.

GMP-compliant biosafety quality control testing of commercial unprocessed bulk is a key part of pre-license inspections for biologics seeking marketing authorization in the European Union and remains a focus in routine inspections of commercial products. The four-day inspection covered areas such as quality management, facilities and equipment, testing methods, standard operating procedures, computerized systems and personnel. The Suzhou facility's quality system, infrastructure, technical capabilities, data integrity and organizational management were highly recognized by the EMA.

Dr. Chris Chen, CEO of WuXi Biologics, commented: "From preliminary safety validation at cell bank and harvest stages to final quality control at commercial batch release, biosafety testing spans critical stages across the entire lifecycle of biologics, ensuring compliance with rigorous regulatory requirements from development through commercialization. We remain committed to maintaining a high-quality system aligned with global GMP standards as a cornerstone to ensure product quality. This capability is consistently demonstrated and implemented across our global network, reflecting our long-standing commitment to enabling our partners and ultimately benefiting patients worldwide."

WuXi Biologics' Biosafety Testing Center has two facilities in Suzhou and Shanghai, offering comprehensive services including cell bank characterization for CHO, HEK293, and E. coli expression systems, diverse biologics biosafety testing, GMP-compliant release testing for commercial products, and GLP-compliant viral clearance studies supported by high-quality in-house virus production platform. As of December 2025, WuXi Biologics' Biosafety Testing Center has successfully enabled over 1,700 IND or BLA applications. Its high-quality system and technical capabilities have been widely recognized by global regulatory authorities and clients.

In additional to EMA, WuXi Biologics' Biosafety Testing Center has received multiple recognitions from other global regulatory authorities. It has successfully completed remote interactive evaluation by the U.S. Food and Drug Administration (FDA), and has passed inspections by China National Accreditation Service for Conformity Assessment (CNAS), National Medical Products Administration (NMPA), Health Canada (HC), the Therapeutic Goods Administration (TGA) of Australia, and the Pharmaceuticals and Medical Devices Agency (PMDA) of Japan, as well as more than 510 quality audits conducted by global clients.

About WuXi Biologics

WuXi Biologics (stock code: 2269.HK) is a leading global Contract Research, Development and Manufacturing Organization (CRDMO) offering end-to-end solutions that enable partners to discover, develop and manufacture biologics – from concept to commercialization – for the benefit of patients worldwide*.

With over 13,000 employees in China, the United States, Ireland, Germany, and Singapore — including experts and scientists in biologics R&D and manufacturing, technology innovation, and operational excellence — WuXi Biologics leverages its technologies and expertise to deliver efficient, cost-effective, and scalable biologics solutions tailored to meet clients' needs. By embedding digital capability and infrastructure across the full biopharmaceutical value chain, the company turns data, computation, and prediction into transparent client experience, faster development, intelligent operations, and more efficient manufacturing. As of April 30, 2026, WuXi Biologics is supporting 982 integrated client projects, including 78 in Phase III and 25 in commercial manufacturing, with complex modalities representing more than half of the entire project portfolio.

WuXi Biologics regards sustainability as the cornerstone of long-term business growth. The company continuously drives technology innovations to offer advanced end-to-end Green CRDMO solutions for its global partners while demonstrating exemplary Environmental, Social and Governance (ESG) practices. Committed to creating shared value, it collaborates with all stakeholders to foster positive social and environmental impacts, and promote responsible practices that empower the entire value chain.

For more information about WuXi Biologics, please visit: www.wuxibiologics.com.

*The winner of the "2026 Biologics CDMO of the Year" (Large CDMOs) (Life Science Connect / Outsourced Pharma)

*The winner of the "2026 Best Contract Development & Manufacturing Organization Award" (ABEA)

Contacts

Business
[email protected]

Media
[email protected]

Apple Inc. (AAPL.US) is preparing to launch the second-generation iPhone Air in the spring of next year, Bloomberg, citing sources, reported.

The new model is anticipated to add a rear camera for ultra-wide photography. The device is undergoing internal testing at Apple.

While the appearance of the new iPhone Air will remain unchanged, Apple is working to enhance battery life and may achieve this by improving energy efficiency, sources divulged.
~

AASTOCKS Financial News
Website: www.aastocks.com

This article was automatically translated by AI, the Chinese version should be considered the authoritative version. AASTOCKS.com Limited does not guarantee its accuracy or completeness and accepts no liability for any damages or losses arising from the use of this translation.

Microsoft Corporation (MSFT.US) has built a sizable business by selling AI models to Chinese enterprises, as ByteDance has been Microsoft’s largest AI customer in recent years, primarily using OpenAI models, with annual spending on Microsoft’s AI and cloud services estimated to breach USD1 billion, Bloomberg cited sources as saying.

Other Chinese technology companies, including Ant Group, MEITUAN-W (03690.HK) and TENCENT (00700.HK), have also invested heavily in AI models through Microsoft’s Azure cloud services.

Microsoft has reportedly established subsidiaries in China to keep pace with local innovation and serve multinational clients. President Brad Smith testified before Congress that Microsoft’s business in China remains relatively small, accounting for only about 1.5% of the company’s total revenue in 2024.

ByteDance, MEITUAN-W (03690.HK) and TENCENT (00700.HK) have not responded to the report, while an Ant Group spokesperson said the company develops its own AI models and that its core products do not rely on external models.
~

AASTOCKS Financial News
Website: www.aastocks.com

Apple Inc. (AAPL.US) CEO Tim Cook told The Wall Street Journal that the company plans to raise product prices to offset surging costs of memory and storage chips.

He said price hikes are unfortunately unavoidable, adding Apple is making every effort to ease the substantial cost pressure passed on by suppliers and has been working to shield customers from the impact of price hikes, but the current situation has become difficult to sustain.

Cook declined to disclose the specific timing, magnitude or affected products of the planned price increases.

Apple’s next major product launch is likely to take place in September, when the iPhone 18 series is expected to be unveiled, including a new foldable iPhone model.
~

AASTOCKS Financial News
Website: www.aastocks.com